Detalhe da pesquisa
1.
Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas.
Br J Haematol
; 204(3): 839-848, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38009548
2.
Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.
Qual Life Res
; 2024 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38879861
3.
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation.
Eur J Haematol
; 110(3): 289-295, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36413106
4.
Strategies to improve patient-reported outcome completion rates in longitudinal studies.
Qual Life Res
; 29(2): 335-346, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31549365
5.
Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world study.
EJHaem
; 5(2): 316-324, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38633122
6.
Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study.
Eur J Haematol
; 88(6): 485-96, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22404182
7.
Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark.
Blood Cancer J
; 12(1): 16, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35087026
8.
Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study.
Leuk Lymphoma
; 60(8): 1950-1957, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30668181
9.
Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy.
Clin Epidemiol
; 11: 987-996, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31814771
10.
11.
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
Cancer Med
; 6(7): 1807-1816, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28639741
12.
The Danish National Multiple Myeloma Registry.
Clin Epidemiol
; 8: 583-587, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27822103
13.
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.
Blood Cancer J
; 11(4): 70, 2021 04 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33828079
14.
No differential overall or relative survival effect of rituximab in male and female patients with diffuse large B-cell lymphoma: a Danish population-based study of 3783 patients.
Leuk Lymphoma
; 60(11): 2798-2801, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31057011
15.
[Cutaneous and haematological adverse events after methotrexate therapy]. / Kutane og hæmatologiske bivirkninger efter methotrexatbehandling
Ugeskr Laeger
; 177(4): V65620, 2015 01 19.
Artigo
Dinamarquês
| MEDLINE | ID: mdl-25613207